|
National Stock Number(NSN): 6505-01-278-3005 (6505012783005, 012783005)
| NIIN: |
01-278-3005 |
Item Name: |
MULTIVITAMIN TABLET |
INC: |
77777 |
| FSC: |
6505
|
Assignment Date: |
|
CRIT: |
|
IIG: |
77777 |
| ISC: |
5 |
Date Standardized: |
|
HMIC: |
|
DODIC: |
|
| NSC: |
5 |
Cancellation Date: |
Aug-01-1994 |
PMIC: |
A |
FIIG: |
A23900 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
4 |
Originator: |
|
ADPEC: |
|
RPDMRC: |
|
| NIIN: |
01-341-6359 |
Item Name: |
MULTIVITAMIN AND IRON TABLETS |
| FSC: |
6505 |
Replacement Date: |
Aug-01-1994 |
|
INC: |
36129 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
43120 |
63488
|
GOLDLINE LABORATORIES, INC. |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
FRUITY CHEWS WITH IRON |
63488
|
GOLDLINE LABORATORIES, INC. |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC00182-4312-01 |
63488
|
GOLDLINE LABORATORIES, INC. |
H |
3 |
2 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
Q |
|
1 |
|
$1.80 |
BT |
|
C2201X- |
|
H |
| DN |
JDC |
L |
|
Q |
|
1 |
|
$1.80 |
BT |
|
9L----- |
|
H |
| DS |
JDC |
L |
|
Q |
|
1 |
|
$1.80 |
BT |
|
------- |
|
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
R |
NOT DMSB STZD |
|
|
|
|
| DN |
K |
100 TT |
|
|
|
|
| DS |
K |
100 TT |
|
|
|
|
| DS |
R |
NON-STD NON-DMSB REV |
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| TEXT |
GENERAL CHARACTERISTICS ITEM DESCRIPTION |
CONTAINS THE FOLLOWING ACTIVE INGREDIENTS:2500.000 I.U. VITAMIN A,400.000 I.U. VITAMIN D,15.000 I.U. VITAMIN E,60.000 MG VITAMIN C,0.300 MG FOLIC ACID,1.050 MG VITAMIN B1,1.200 MG VITAMIN B2,13.500 MG NIACIN,1.050 MG VITAMIN B6,4.500 MCG VITAMIN B12,12.000 MG IRON,8.000 MG ZINC;CHILDRENS VITAMINS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
|
3 |
H |
|
|
|
|
| FSKX |
|
|
3 |
H |
|
|
|
|
| N9LM |
|
|
3 |
H |
|
|
|
|
|